LATEST

IC/BPS: One-fourth of patients have Hunner lesionsAbout one-fourth of patients with interstitial cystitis/bladder pain syndrome have Hunner lesions in the bladder visible on cystoscopy.
Immediate post-TURBT mitomycin instillation reduces recurrence riskMitomycin C instillation within 24 hours after transurethral resection of non-muscle invasive bladder cancer significantly reduces the risk of recurrence and delays the time to recurrence.
Repeat hydrodistention found safe in treating ICRepeated hydrodistention as therapy for interstitial cystitis has a low complication rate and does not decrease bladder capacity over time.
Are you taking steps to prevent data breaches?"Urologists need to be ever more vigilant to protect the private information under their custodianship," writes Robert A. Dowling, MD.
Foot stimulation may offer home-based OAB treatmentNew research may pave the way for a form of nerve stimulation for refractory overactive bladder that is home based and less invasive than current neuromodulation approaches.
Genomic testing linked to higher surveillance uptakeIn men with clinically low-risk prostate cancer managed in community-based urology practices, utilization of active surveillance as initial management is higher among those who undergo genomic testing.
MedPAC advocates for MIPS terminationIf members of the Medicare Payment Advisory Commission have their way, the new Merit-based Incentive Payment System will be sent into oblivion, never to be heard of again.
Senate takes aim at pharmacy benefit managers’ role in rising drug costsA recently proposed bill “offers transparency measures that provide stakeholders further elucidation of how money moves through the pharmaceutical supply chain,” writes the AACU’s Brian Henderson.
SUI: Phase III data offer lessons for trials evaluating cell therapyResults of one of the first randomized controlled trials evaluating cell therapy for women with stress urinary incontinence (SUI) has helped to identify clinically meaningful efficacy endpoints to refine patient selection criteria for current and future studies, according to investigator Melissa R. Kaufman, MD, PhD.
Bother, symptom severity often poorly correlated in LUTSThe correlation between patient-reported bother and symptom severity is inexact, according to conclusions of a recent retrospective multicenter study of nearly 1,200 patients referred for lower urinary tract symptoms.

Poll